Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2022 · 10-Q
Revenue$2.50B$2.50B+0.4% vs Q2 2021 Net Income$28.60M$28.60M−56.6% vs Q2 2021 EPS Diluted$0.37$0.37−57.5% vs Q2 2021 Gross Profit$532,505,000+33.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$89,825,000N/M Free Cash Flowderived$37,198,000N/M Margins · derivedGross margin21.3%+5.2 pt vs Q2 2021
Operating margin3.0%−0.9 pt vs Q2 2021
Net margin1.1%−1.5 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 3, 2022 · 34 d after period end